Skip to main content
Clinical Trials/NCT05828030
NCT05828030
Recruiting
Not Applicable

Noninvasive Ventilation With High Flow Nasal Cannula Compared With Facial Mask in Patients With Chest Trauma: a Randomized Controlled Study

National Taiwan University Hospital2 sites in 1 country100 target enrollmentApril 26, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Chest Trauma
Sponsor
National Taiwan University Hospital
Enrollment
100
Locations
2
Primary Endpoint
Rate of event of intubation or pneumonia
Status
Recruiting
Last Updated
7 months ago

Overview

Brief Summary

Guidelines for noninvasive ventilation (NIV) recommend continuous positive airway pressure in patients with thoracic trauma who remain hypoxic . However, no any suggestion was applied for high flow nasal cannula (HFNC). Therefore, Our aim was to determine whether HFNC reduces intubation in severe trauma-related hypoxemia.

Detailed Description

This would be a three-center randomized clinical trial of a level I trauma hospital. Inclusion criteria were patients with Arterial oxygen level (Pao2/)fraction of inspired oxygen inspired oxygen fraction(Fio2)\<300 while receiving oxygen by high-flow mask within the first 72 h after thoracic trauma. Patients were randomized to remain on high-flow oxygen mask/ noninvasive ventilation or to receive HFNC. The interface was selected based on the associated injuries.

Registry
clinicaltrials.gov
Start Date
April 26, 2023
End Date
December 31, 2027
Last Updated
7 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients who have the following condition within 72 hours of chest trauma despite receiving standard nasal cannula oxygen therapy \[≥10 L/min\], are eligible for inclusion.
  • severe hypoxemic respiratory failure \[Arterial partial pressure of oxygen (PaO2)/fraction of inspired oxygen fraction(FiO2) \<300 mmHg\]
  • with a respiratory rate \>25 breaths/minute and difficulty breathing, or respiratory distress
  • PaCO2 of 45 mmHg or higher (if the patient requires emergency surgery with endotracheal intubation and mechanical ventilation, the time of inclusion will be the start of the post-extubation period. (Note: For patients who receive emergency trauma surgery with endotracheal intubation and mechanical ventilation, the time of inclusion assessment will be 72 hours after extubation.)

Exclusion Criteria

  • Patients with a Glasgow Coma Scale less than 8 or severe brain injury.
  • Patients with any contraindications to non-invasive ventilation, including acute gastrointestinal bleeding, upper airway obstruction, or hemodynamic instability.
  • Facial trauma involving skull base fractures, facial bone fractures, or orbital floor fractures.
  • Severe injuries involving the nasal sinuses.
  • Patients with cervical spine injuries.
  • Patients with increased intracranial pressure.
  • Patients with facial, nasal, or airway structural abnormalities or surgery that prevents the use of appropriate nasal cannula.
  • Patients after upper airway surgery.
  • Patients who are unable to clearly express their willingness to sign informed consent.

Outcomes

Primary Outcomes

Rate of event of intubation or pneumonia

Time Frame: 30 days after randomization

Intubation criteria included a respiratory rate of \>40 breaths per minute, signs of increased breathing effort, SpO2 of \<90% despite high fraction of inspired oxygen inspired oxygen fraction or acidosis with the quantitative measure of the acidity or basicity of aqueous or other liquid solutions (pH scale) of \<7.35, occurrence of hemodynamic instability or deterioration of neurologic status.

Secondary Outcomes

  • P/F ratio(48 hrs after randomization)
  • pneumonia rate /tracheostomy rate(30 days after randomization)

Study Sites (2)

Loading locations...

Similar Trials